Mesenteric ischemia

Displaying 1 study

  • A Study to Evaluate the Effectiveness and Safety of Apraglutide in Adults with Short Bowel Syndrome and Intestinal Failure Rochester, MN

    The primary purpose of this study is to evaluate the effectiveness of Apraglutide (5 mg subcutaneously (SC), once weekly) in reducing the administered volume per week of PS from baseline, compared with placebo in adults with Short Bowel Syndrome and Intestinal Failure.

    Short bowel syndrome is a malabsorptive condition characterized by extreme reduction in functional small intestinal length most commonly as a result of surgical resection due to mesenteric ischemia or Inflammatory Bowel Disease (IBD) although other etiologies are also present. 


Mayo Clinic Footer